ai screening for dr and chronic diseases
play

AI Screening for DR and Chronic Diseases 2018-03-29 Emma Xu, Dr. You Li Impact of Blindness in Elderly Survival Curve for All-cause Mortality in Singapore Malay Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye

0 downloads 3 Views 7,06 MB Size Report
  1. AI Screening for DR and Chronic Diseases 2018-03-29 Emma Xu, Dr. You Li

  2. Impact of Blindness in Elderly Survival Curve for All-cause Mortality in Singapore Malay Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye Study (SiMES) Scientific Reports volume 5 , Article number: 16304 (2015)

  3. Outline • Why are there high rate for blindness in China • How AI can be used for the early detection of eye diseases • How AI DR screening is used in hospital

  4. Patients of Blinding Diseases in China • Blindness or Low Vision: 1 / 20 • No. of Patients Age-related • Cataract: 60 million Age-related Macula 30 million Degeneration: Glaucoma: 10 million • Chronic-diseases-related 12 million Diabetic Retinopathy: Retinal Vessel 7 million Occlusion:

  5. Example: Diabetic Retinopathy (DR) Taking fundus image Healthy Fundus Fundus with DR Lesions

  6. Deficiency of Ophthalmologists in the Rural China 1/5 County Hospitals have Ophthalmology Department 40% - 200% Higher prevalence of blindness than cities

  7. AI Fundus Screening Algorithm 8.37M Fundus Photos 100+ professors/3yrs Cross labelling 30+ Diseases Recognized 2 million fundus photos Uploaded in 2017

  8. Architecture Web Server UI Data Flow Annotation Storage Training System Storage Nvidia DR Grading GPU Server Lesion Detection General Classification Macula detection Cataract Classification Client Web Server Glaucoma Service …… Front-end GPU Server Computer or smart device AI services: Recognition/detection/inference.

  9. Community Screening for Elderly in 4 rd -tier Cities Disease found in 60+ yrs 2/3 Positive 15% have whole-body chronic diseases 80% did not know the disease before 90% will go to hospital 28% Cataract: 14% Retinal Arteriosclerosis: 10% Age-Related Macular Degeneration: 2.1% Diabetic Retinopathy:

  10. Screening for Working Population 21% Positive 10% Need to see a doctor 85% Did not know the disease before Age-related Macula 5% Degeneration: Probable 4% : Glaucoma: Pathological Myopia: 2.6% Retinal 2.3% Arteriosclerosis:

  11. Prof. Li: Airdoc AI in DR screening • Li You M.D. • Dr. of Ophthalmology • Professor of Medicine • Chief Physician • Department of Ophthalmology, Changzheng Hospital Shanghai, China

  12. Prof. Li: Airdoc AI the screening of DR(Diabetic Retinopathy)

  13. Probably the Most Famous DR Patient

  14. What exactly is DR? No apparent symptom in early stage Irreversible lesion Lower the risk of blindness by controlling on time Early Intervention to lower risk of glaucoma

  15. DR Prevalence Patients of Diabetes 110 million DR Prevalence in Patients of Diabetes Prevalence of DR in Patients of Diabetes 25%-40% NDR: 62.5%-75.3% No. of Ophthalmologists 35,000 NPDR: 21.4%-30.1% No. of Doctors/No. of DR Patients PDR: 3.3%-7.4% 1/3250 DME: 5.2% CDME: 3.5%

  16. Romote Regions of China Need Medicine and Doctors

  17. Cataract Operation in Village

  18. Later Period of Glaucoma TAO

  19. Deep Learning in DR Automatic Detection on lesions

  20. Features of Airdoc DR • Accuracy in DR grading • Lesion Detection • Seamless integration with fundus cameras

  21. DR Patient found by Airdoc AI :Mr. Sheng

  22. The Future of Fundus Screening More chronic diseases are found to be related to lesions in fundus • Senile Dementia • Parkinson • AIDS • Cerebral Stroke • Coronary Heart Disease • Nephropathy • Cerebral Small Vessel Disease(CSVD)

  23. Thank You! emma@airdoc.com

Recommend Documents


www who int chp did you know chronic diseases
www.who.int/chp Did you know??

www.who.int/chp Did you know?? Chronic diseases Cardiovascular disease,

who int chp did you know chronic diseases
www.who.int/chp Did you know??

www.who.int/chp Did you know?? Chronic diseases Cardiovascular disease,

september 2016 prevalence of chronic diseases
September, 2016 Prevalence of Chronic

Esther Devall FCS Program Leaders Meeting September, 2016 Prevalence of

treatment of chronic diseases with living foods
Treatment of Chronic Diseases With

Treatment of Chronic Diseases With Living Foods Dr. Bernadette Janczak, ND

healthy living cancer prevention chronic diseases
Healthy Living & Cancer Prevention

Healthy Living & Cancer Prevention Chronic Diseases Modifiable Risk

chronic illness
Chronic illness Lindsey Gardner,

Chronic illness Lindsey Gardner, Leslie Wells, Kimberlyn Jaggers

oaic annual meeting plenary session age and sex are the
OAIC Annual Meeting Plenary Session

OAIC Annual Meeting Plenary Session Age and Sex are THE drivers of most

additional module 2 specific health concerns
ADDITIONAL MODULE 2. SPECIFIC HEALTH

ADDITIONAL MODULE 2. SPECIFIC HEALTH CONCERNS Unit 1. Chronic Diseases

8 6 2014
8/6/2014 Chronic Wasting Disease (CWD)

8/6/2014 Chronic Wasting Disease (CWD) Facts Belongs to a family of diseases

screening practices for infectious diseases among newly
Screening practices for infectious

Screening practices for infectious diseases among newly arrived migrants in

eye health from a z
Eye Health from A Z Did You Know?

Eye Health from A Z Did You Know? 13.5 Vision problems affect nearly

apl 2 treatment for geographic atrophy long term results
APL-2 Treatment For Geographic Atrophy:

APL-2 Treatment For Geographic Atrophy: Long-term Results David Brown, MD

l e adi ng re ge ne rat i ve me di ci ne
L E ADI NG RE GE NE RAT I VE

L E ADI NG RE GE NE RAT I VE ME DI CI NE May 2014 pr e se nte d

interim
Interim results 2019 synconaltd.com

Interim results 2019 synconaltd.com Image Freeline labs, Stevenage Notice

creating a world of bionic vision for those who have lost
Creating a world of bionic vision for

Creating a world of bionic vision for those who have lost their sight

efficacy of complement c3 inhibition in preclinical
Efficacy of Complement C3 Inhibition in

Poster # B0268 Efficacy of Complement C3 Inhibition in Preclinical Models of

employee benefit
Employee Benefit Presentation 1 WHO,

2020-2021 Employee Benefit Presentation 1 WHO, WHAT , WHY ? Who:

14 april 2018
14 April 2018 Slide 2 Agenda The New

Slide 1 GORING AND WOODCOTE MEDICAL PRACTICE PATIENT PARTICIPATION GROUP

corporate presentation forward looking statements
Corporate Presentation Forward-Looking

Corporate Presentation Forward-Looking Statements This presentation has been

revenio acquires centervue
Revenio acquires CenterVue 15.4.2019

Revenio acquires CenterVue 15.4.2019 CEO T Tim imo H Hild ildn CFO

the hta view
The HTA View Professor David Barnett

EMA-HTA Workshop Parallel Advice in Scientific Drug Development The HTA View

steven prawer
Steven Prawer Bionic Vision Australia,

Steven Prawer Bionic Vision Australia, University of Melbourne Victoria The